Analysis of mitosis and antimitotic drug responses in tumors by in vivo microscopy and single-cell pharmacodynamics.
Analysis of mitosis and antimitotic drug responses in tumors by in vivo microscopy and single-cell pharmacodynamics.
复制标题
DOI:
10.1158/0008-5472.can-11-0412
复制
发表时间:
2011-07-01
期刊:
影响因子:
11.2
通讯作者:
Mitchison TJ
中科院分区:
文献类型:
--
作者:
Orth JD;Kohler RH;Foijer F;Sorger PK;Weissleder R;Mitchison TJ
Cancer relies upon frequent or abnormal cell division but how the tumor microenvironment affects mitotic processes in vivo remains unclear, largely due to the technical challenges of optical access, spatial resolution, and motion. We developed high-resolution in vivo microscopy methods to visualize mitosis in a murine xenograft model of human cancer. Using these methods, we determined whether the single-cell response to the anti-mitotic drug paclitaxel was the same in tumors as in cell culture; observed the impact of paclitaxel (Ptx) on the tumor response as a whole; and evaluated the single-cell pharmacodynamics of paclitaxel (by in vivo pharmacodynamic microscopy [IPDM]). Mitotic initiation was generally less frequent in tumors than in cell culture, but subsequently it proceeded normally. Paclitaxel treatment caused spindle assembly defects and mitotic arrest, followed by slippage from mitotic arrest, multinucleation and apoptosis. Compared to cell culture, the peak mitotic index in tumors exposed to paclitaxel was lower and the tumor cells survived longer after mitotic arrest, becoming multinucleated rather than dying directly from mitotic arrest. Thus, the tumor microenvironment was much less pro-apoptotic than cell culture. The morphologies associated with mitotic arrest were dose- and time-dependent, thereby providing a semi-quantitative, single-cell measure of pharmacodynamics. Although many tumor cells did not progress through Ptx-induced mitotic arrest, tumor significantly regressed in the model. Our findings demonstrate that in vivo microscopy offers a useful tool to visualize mitosis during tumor progression, drug responses, and cell fate at the single cell level.